10 Best Growth Stocks Under $20 to Buy
In this article, we will discuss the 10 Best Growth Stocks Under $20 to Buy.
Monte Rosa Therapeutics Inc. (GLUE)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Vestal Point Capital Ryan Wilder | 4,600,000 | $111,320,000 | +28% | 2.6% |
| 2. | Biotechnology Value Fund / BVF Inc Mark Lampert | 4,460,886 | $107,953,441 | 2.76% | |
| 3. | Baker Bros. Advisors Julian Baker And Felix Baker | 4,345,736 | $105,166,811 | 0.53% | |
| 4. | Suvretta Capital Management Aaron Cowen | 3,549,539 | $85,898,844 | -17% | 1.57% |
| 5. | Braidwell LP Alex Karnal | 2,451,562 | $59,327,800 | -24% | 2.19% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $5.84 | 10,000 | $58,383.00 | 10,000 | 2025-03-24 | Filing | |
| $19.00 | 1,050,000 | $19,950,000.00 | 7,692,298 | 2021-06-28 | Filing | |
| $19.00 | 1,050,000 | $19,950,000.00 | 7,692,298 | 2021-06-28 | Filing | |
| $19.00 | 1,050,000 | $19,950,000.00 | 7,692,298 | 2021-06-28 | Filing | |
| $19.00 | 1,050,000 | $19,950,000.00 | 7,692,298 | 2021-06-28 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $23.18 | 9,500 | $220,218.55 | 585,038 | 2026-07-16 | Filing | |
| $23.38 | 4,351 | $101,729.86 | 62,371 | 2026-07-15 | Filing | |
| $24.13 | 400 | $9,652.00 | 67,845 | 2026-07-06 | Filing | |
| $23.25 | 5,600 | $130,197.20 | 68,245 | 2026-07-06 | Filing | |
| $24.50 | 5,407 | $132,471.50 | 60,612 | 2026-06-30 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 7,692,298 | $186,153,612 | 11.72% | |
| 2. | 6,843,087 | $165,602,706 | 0% | |
| 3. | 4,622,151 | $111,856,054 | 2.69% | |
| 4. | 3,731,416 | $90,300,267 | 0% | |
| 5. | 3,412,927 | $82,592,833 | 0% |
News See All
Pallas Capital Backs Monte Rosa Therapeutics, Inc. (GLUE) Amid Growth Prospects
Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE) is among the best fast money stocks to buy now. During the second quarter, Pallas Capital Advisors acquired a new position in Monte Rosa Therapeutics, Inc.
11 Best Fast Money Stocks to Buy Now
In this article, we will take a look at some of the best fast money stocks to buy now. In this fast-paced world, most people have become impatient.
Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE) Q4 2024 Earnings Call Transcript
Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE) Q4 2024 Earnings Call Transcript March 20, 2025Monte Rosa Therapeutics, Inc. beats earnings expectations. Reported EPS is $0.23, expectations were $-0.37.
Alphabet Inc (GOOGL) Investment Portfolio: Top 15 Companies
In this article, we discuss the top 15 companies in Alphabet Inc (GOOGL)’s investment portfolio.
Hedge Fund Resource Center